Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.
D000200:Action Potentials / Q000187:drug effects; D000281:Administration, Intranasal; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000402:Airway Obstruction / Q000188:drug therapy; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002648:Child; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004341:Drug Evaluation; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007700:Kinetics; D008407:Mast Cells / Q000187:drug effects; D005082:Physical Exertion; D011941:Receptors, Adrenergic / Q000187:drug effects; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D011941:Receptors, Adrenergic; D006632:Histamine; D004205:Cromolyn Sodium